Home » Stocks » Armata Pharmaceuticals

Armata Pharmaceuticals, Inc. (ARMP)

Stock Price: $3.53 USD -0.13 (-3.42%)
Updated Aug 10, 2020 11:05 AM EDT - Market open

Stock Price Chart

Key Info

Market Cap 65.72M
Revenue (ttm) n/a
Net Income (ttm) -20.82M
Shares Out 18.64M
EPS (ttm) -2.35
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 10, 2020
Last Price $3.53
Previous Close $3.65
Change ($) -0.13
Change (%) -3.42%
Day's Open 3.65
Day's Range 3.37 - 3.65
Day's Volume 24,475
52-Week Range 2.52 - 6.92

More Stats

Market Cap 65.72M
Enterprise Value 43.47M
Earnings Date (est) Nov 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 18.64M
Float 6.94M
EPS (basic) -2.22
EPS (diluted) -2.35
FCF / Share -1.67
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 49,123
Short Ratio 1.58
Short % of Float 0.40%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 2.18
Revenue n/a
Operating Income -21.23M
Net Income -20.82M
Free Cash Flow -17.42M
Net Cash 22.26M
Net Cash / Share 1.19
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -43.92%
ROE -111.22%
ROIC -144.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 4
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$7.25*
(105.67% upside)
Low
5.00
Current: $3.53
High
9.00
Target: 7.25
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015201420132012
Revenue--0.120.260.480.410.080.66
Revenue Growth---55.77%-45.26%16.14%404.94%-87.8%-
Gross Profit--0.120.260.480.410.080.66
Operating Income-19.75-17.66-16.16-23.38-10.23-14.11-12.38-4.02
Net Income-19.48-16.70-12.84-18.84-0.5223.11-64.58-1.11
Shares Outstanding7.834.650.460.070.040.030.010.01
Earnings Per Share-2.55-3.59-30.52-345.37-278.59-326.19-4,479.91-140.00
Operating Cash Flow-15.58-10.63-9.19-10.61-9.78-12.57-6.29-4.28
Capital Expenditures-0.13-0.81-0.06-0.28-0.21-1.20-0.10-0.05
Free Cash Flow-15.71-11.44-9.25-10.89-9.99-13.77-6.39-4.33
Cash & Equivalents6.7310.465.135.719.376.5820.360.86
Total Debt2.86--0.80---3.65
Net Cash / Debt3.8710.465.134.919.376.5820.36-2.79
Assets25.4514.5511.1418.1531.4928.6241.2122.07
Liabilities10.866.853.418.436.8923.1963.139.13
Book Value14.597.697.739.7212.713.44-22.6312.94
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Armata Pharmaceuticals, Inc.
Country United States
Employees 33
CEO Todd R. Patrick

Stock Information

Ticker Symbol ARMP
Stock Exchange NYSE American
Sector Healthcare
Industry Biotechnology
Unique Identifier NYSEAMERICAN: ARMP

Description

Armata Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for the treatment of antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates includes AP-SA02, which is in Phase 1b/2 clinical trial and AP-SA01 that targets staphylococcus aureus, including multidrug-resistant strains. It is also developing and advancing AP-PA02 that is in Phase 1b/2 clinical trial for treating diseases caused by pseudomonas aeruginosa. The company is headquartered in Marina del Rey, California.